Stock Track | Senseonics Soars 5.13% After-Hours on Strong Q3 Results and Reverse Stock Split Announcement

Stock Track

Oct 08

Senseonics Holdings Inc. (AMEX:SENS) saw its stock surge 5.13% in after-hours trading on Tuesday, following the release of impressive preliminary third-quarter results and the announcement of a reverse stock split. This positive movement comes as a stark contrast to the stock's performance during regular trading hours, where it had fallen 17.5%.

The diabetes care technology company reported preliminary Q3 FY25 revenue of approximately $8.1 million, surpassing the consensus estimate of $7.8 million. This represents a substantial 91% year-over-year increase, driven by remarkable growth in new U.S. patients. Senseonics also recorded its highest-ever monthly new patient starts in September 2025, showcasing the growing adoption of its Eversense continuous glucose monitoring system.

Adding to the news, Senseonics announced a one-for-twenty reverse stock split, set to take effect on October 17, 2025. This move will reduce the total outstanding shares from approximately 816 million to roughly 41 million. The company's CEO, Tim Goodnow, expressed confidence in their ability to drive top-line revenue growth, citing the success of their direct-to-consumer marketing campaigns. With the recent decision to bring the full sales and marketing organization in-house, Senseonics appears poised for continued growth in the competitive diabetes care market.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/news/1177191294"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1177191294\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1177191294?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-10-08 05:24","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1177191294","market":"nz","top_or_hot":-1,"title":"Stock Track | Senseonics Soars 5.13% After-Hours on Strong Q3 Results and Reverse Stock Split Announcement","media":"Stock Track","content":"<p>Senseonics Holdings Inc. (AMEX:SENS) saw its stock surge 5.13% in after-hours trading on Tuesday, following the release of impressive preliminary third-quarter results and the announcement of a reverse stock split. This positive movement comes as a stark contrast to the stock's performance during regular trading hours, where it had fallen 17.5%.</p>\n\n<p>The diabetes care technology company reported preliminary Q3 FY25 revenue of approximately $8.1 million, surpassing the consensus estimate of $7.8 million. This represents a substantial 91% year-over-year increase, driven by remarkable growth in new U.S. patients. Senseonics also recorded its highest-ever monthly new patient starts in September 2025, showcasing the growing adoption of its Eversense continuous glucose monitoring system.</p>\n\n<p>Adding to the news, Senseonics announced a one-for-twenty reverse stock split, set to take effect on October 17, 2025. This move will reduce the total outstanding shares from approximately 816 million to roughly 41 million. The company's CEO, Tim Goodnow, expressed confidence in their ability to drive top-line revenue growth, citing the success of their direct-to-consumer marketing campaigns. With the recent decision to bring the full sales and marketing organization in-house, Senseonics appears poised for continued growth in the competitive diabetes care market.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Senseonics Soars 5.13% After-Hours on Strong Q3 Results and Reverse Stock Split Announcement</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Senseonics Soars 5.13% After-Hours on Strong Q3 Results and Reverse Stock Split Announcement\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-10-08 05:24</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Senseonics Holdings Inc. (AMEX:SENS) saw its stock surge 5.13% in after-hours trading on Tuesday, following the release of impressive preliminary third-quarter results and the announcement of a reverse stock split. This positive movement comes as a stark contrast to the stock's performance during regular trading hours, where it had fallen 17.5%.</p>\n\n<p>The diabetes care technology company reported preliminary Q3 FY25 revenue of approximately $8.1 million, surpassing the consensus estimate of $7.8 million. This represents a substantial 91% year-over-year increase, driven by remarkable growth in new U.S. patients. Senseonics also recorded its highest-ever monthly new patient starts in September 2025, showcasing the growing adoption of its Eversense continuous glucose monitoring system.</p>\n\n<p>Adding to the news, Senseonics announced a one-for-twenty reverse stock split, set to take effect on October 17, 2025. This move will reduce the total outstanding shares from approximately 816 million to roughly 41 million. The company's CEO, Tim Goodnow, expressed confidence in their ability to drive top-line revenue growth, citing the success of their direct-to-consumer marketing campaigns. With the recent decision to bring the full sales and marketing organization in-house, Senseonics appears poised for continued growth in the competitive diabetes care market.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SENS","symbol_name":"Senseonics Holdings,Inc.","start_time":0,"source_url":"","article_id":"1177191294","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1177191294","pubTimestamp":1759872260,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Senseonics Holdings Inc. (AMEX:SENS) saw its stock surge 5.13% in after-hours trading on Tuesday, following the release of impressive preliminary third-quarter results and the announcement of a...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SENS":"Senseonics Holdings,Inc."},"translate_title":"个股追踪|Senseonics盘后大涨5.13%，因Q3业绩强劲及反向拆股公告","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SENS":1},"content_text":"Senseonics Holdings Inc. (AMEX:SENS) saw its stock surge 5.13% in after-hours trading on Tuesday, following the release of impressive preliminary third-quarter results and the announcement of a reverse stock split. This positive movement comes as a stark contrast to the stock's performance during regular trading hours, where it had fallen 17.5%.\nThe diabetes care technology company reported preliminary Q3 FY25 revenue of approximately $8.1 million, surpassing the consensus estimate of $7.8 million. This represents a substantial 91% year-over-year increase, driven by remarkable growth in new U.S. patients. Senseonics also recorded its highest-ever monthly new patient starts in September 2025, showcasing the growing adoption of its Eversense continuous glucose monitoring system.\nAdding to the news, Senseonics announced a one-for-twenty reverse stock split, set to take effect on October 17, 2025. This move will reduce the total outstanding shares from approximately 816 million to roughly 41 million. The company's CEO, Tim Goodnow, expressed confidence in their ability to drive top-line revenue growth, citing the success of their direct-to-consumer marketing campaigns. With the recent decision to bring the full sales and marketing organization in-house, Senseonics appears poised for continued growth in the competitive diabetes care market.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}